Logo image of BONE.CA

BORON ONE HOLDINGS INC (BONE.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:BONE - CA10002E1060 - Common Stock

0.055 CAD
0 (0%)
Last: 12/29/2025, 7:00:00 PM
Fundamental Rating

1

BONE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 804 industry peers in the Metals & Mining industry. BONE may be in some trouble as it scores bad on both profitability and health. BONE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BONE has reported negative net income.
BONE had a negative operating cash flow in the past year.
In the past 5 years BONE always reported negative net income.
In the past 5 years BONE always reported negative operating cash flow.
BONE.CA Yearly Net Income VS EBIT VS OCF VS FCFBONE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -500K -1M -1.5M -2M

1.2 Ratios

With a decent Return On Assets value of -9.66%, BONE is doing good in the industry, outperforming 60.20% of the companies in the same industry.
With a decent Return On Equity value of -10.05%, BONE is doing good in the industry, outperforming 64.30% of the companies in the same industry.
Industry RankSector Rank
ROA -9.66%
ROE -10.05%
ROIC N/A
ROA(3y)-8.56%
ROA(5y)-9.46%
ROE(3y)-9.07%
ROE(5y)-10.05%
ROIC(3y)N/A
ROIC(5y)N/A
BONE.CA Yearly ROA, ROE, ROICBONE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BONE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BONE.CA Yearly Profit, Operating, Gross MarginsBONE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, BONE has more shares outstanding
BONE has more shares outstanding than it did 5 years ago.
BONE has a better debt/assets ratio than last year.
BONE.CA Yearly Shares OutstandingBONE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
BONE.CA Yearly Total Debt VS Total AssetsBONE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

BONE has an Altman-Z score of 14.73. This indicates that BONE is financially healthy and has little risk of bankruptcy at the moment.
BONE's Altman-Z score of 14.73 is fine compared to the rest of the industry. BONE outperforms 68.91% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that BONE is not too dependend on debt financing.
The Debt to Equity ratio of BONE (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 14.73
ROIC/WACCN/A
WACCN/A
BONE.CA Yearly LT Debt VS Equity VS FCFBONE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 0.43 indicates that BONE may have some problems paying its short term obligations.
BONE has a worse Current ratio (0.43) than 74.63% of its industry peers.
BONE has a Quick Ratio of 0.43. This is a bad value and indicates that BONE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.43, BONE is doing worse than 73.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43
BONE.CA Yearly Current Assets VS Current LiabilitesBONE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

BONE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.00%.
EPS 1Y (TTM)-96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
BONE.CA Price Earnings VS Forward Price EarningsBONE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BONE.CA Per share dataBONE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BONE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

BORON ONE HOLDINGS INC

TSX-V:BONE (12/29/2025, 7:00:00 PM)

0.055

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.83%
Ins Owner ChangeN/A
Market Cap13.67M
Revenue(TTM)N/A
Net Income(TTM)-1.10M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 1.24
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.66%
ROE -10.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-8.56%
ROA(5y)-9.46%
ROE(3y)-9.07%
ROE(5y)-10.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2434.74%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z 14.73
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2378.76%
Cap/Depr(5y)2067.26%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.89%
OCF growth 3YN/A
OCF growth 5YN/A

BORON ONE HOLDINGS INC / BONE.CA FAQ

Can you provide the ChartMill fundamental rating for BORON ONE HOLDINGS INC?

ChartMill assigns a fundamental rating of 1 / 10 to BONE.CA.


What is the valuation status for BONE stock?

ChartMill assigns a valuation rating of 0 / 10 to BORON ONE HOLDINGS INC (BONE.CA). This can be considered as Overvalued.


Can you provide the profitability details for BORON ONE HOLDINGS INC?

BORON ONE HOLDINGS INC (BONE.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for BONE stock?

The financial health rating of BORON ONE HOLDINGS INC (BONE.CA) is 3 / 10.